Petter Wereen Email

VP Procurement and Business Development . Orexo

Current Roles

Employees:
142
Revenue:
$28.5M
About
Orexo develops improved pharmaceuticals based on innovative drug delivery technologies. The focus is primarily on opioid dependence and pain but it is also our aim to address other therapeutic areas where our competence and technologies can create value. The main market today is the American market for buprenorphine/naloxone products, where Orexo commercialize the product Zubsolv®. Other products are commercialized through partners, including sale of Zubsolv outside the US.
Orexo Address
150 Headquarters Plaza
Morristown, NJ
United States

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.